|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rodriguez Martinez RH, Rueda Buisan O and
Ibarz L: Bladder cancer: Present and future. Med Clin. 149:449–455.
2017.
|
|
3
|
Kaufman DS, Shipley WU and Feldman AS:
Bladder cancer. Lancet. 374:239–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thompson DB, Siref LE, Feloney MP, Hauke
RJ and Agrawal DK: Immunological basis in the pathogenesis and
treatment of bladder cancer. Expert Rev Clin Immunol. 11:265–279.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Croxford AL, Mair F and Becher B: IL-23:
One cytokine in control of autoimmunity. Eur J Immunol.
42:2263–2273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang P, Yang B, Zhou B, Zhang J, Li S,
Jiang J, Sun Z and Jin F: Distribution and expression profiles of
dendritic cell subpopulations in human bladder cancer. Int J Clin
Exp Pathol. 9:7180–7187. 2016.
|
|
7
|
Segura E, Touzot M, Bohineust A, Cappuccio
A, Chiocchia G, Hosmalin A, Dalod M, Soumelis V and Amigorena S:
Human inflammatory dendritic cells induce Th17 cell
differentiation. Immunity. 38:336–348. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Croxford AL, Kulig P and Becher B:
IL-12-and IL-23 in health and disease. Cytokine Growth Factor Rev.
25:415–421. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gagliani N, Hu B, Huber S, Elinav E and
Flavell RA: The fire within: Microbes inflame tumors. Cell.
157:776–783. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tugues S, Burkhard SH, Ohs I, Vrohlings M,
Nussbaum K, Berg Vom J, Kulig P and Becher B: New insights into
IL-12-mediated tumor suppression. Cell Death Differ. 22:237–246.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang K and Karin M: The IL-23 to IL-17
cascade inflammation-related cancers. Clin Exp Rheumatol. 33 4
Suppl 92:S87–S90. 2015.PubMed/NCBI
|
|
12
|
Teng MW, Andrews DM, McLaughlin N, von
Scheidt B, Ngiow SF, Möller A, Hill GR, Iwakura Y, Oft M and Smyth
MJ: IL-23 suppresses innate immune response independently of IL-17A
during carcinogenesis and metastasis. Proc Natl Acad Sci USA.
107:8328–8333. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sobin L, Gospodarowicz M and Wittekind C:
TNM classification of malignant tumors., in U1CC 1nternational
Union Against Cancer. Wiley-Blackwell. 262–265. 2009.
|
|
14
|
Kindelan Alvarez J, Campos Hernández JP,
López Beltrán A and Requena Tapia MJ: The 2004 WHO classification
of bladder tumors: A summary and commentary. Actas Urol Esp.
31:978–988. 2007.(In Spanish). PubMed/NCBI
|
|
15
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cancer Genome Atlas Research Network:
Comprehensive molecular characterization of urothelial bladder
carcinoma. Nature. 507:315–522. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qian X, Gu L, Ning H, Zhang Y, Hsueh EC,
Fu M, Hu X, Wei L, Hoft DF and Liu J: Increased Th17 cells in the
tumor microenvironment is mediated by IL-23 via tumor-secreted
prostaglandin E2. J Immunol. 190:5894–5902. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee JS, Leem SH, Lee SY, Kim SC, Park ES,
Kim SB, Kim SK, Kim YJ, Kim WJ and Chu IS: Expression signature of
E2F1 and its associated genes predict superficial to invasive
progression of bladder tumors. J Clin Oncol. 28:2660–2667. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sanchez-Carbayo M, Socci ND, Lozano J,
Saint F and Cordon-Cardo C: Defining molecular profiles of poor
outcome in patients with invasive bladder cancer using
oligonucleotide microarrays. J Clin Oncol. 24:778–789. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cancer Genome Atlas Research, Network:
Comprehensive genomic characterization defines human glioblastoma
genes and core pathways. Nature. 455:1061–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Singh M, Yelle N, Venugopal C and Singh
SK: EMT: Mechanisms and therapeutic implications. Pharmacol Ther.
182:80–94. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dominguez C, David JM and Palena C:
Epithelial-mesenchymal transition and inflammation at the site of
the primary tumor. Semin Cancer Biol. 47:177–184. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kanda Y, Osaki M and Okada F:
Chemopreventive strategies for inflammation-related carcinogenesis:
Current status and future direction. Int J Mol Sci. 18:pii:
E8672017. View Article : Google Scholar
|
|
25
|
Ngiow SF, Teng MW and Smyth MJ: A balance
of interleukin-12 and −23 in cancer. Trends Immunol. 34:548–555.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Langowski JL, Kastelein RA and Oft M:
Swords into plowshares: IL-23 repurposes tumor immune surveillance.
Trends Immunol. 28:207–212. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Langowski JL, Zhang X, Wu L, Mattson JD,
Chen T, Smith K, Basham B, McClanahan T, Kastelein RA and Oft M:
IL-23 promotes tumour incidence and growth. Nature. 442:461–465.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chugh S, Anand V, Swaroop L, Sharma M,
Seth A and Sharma A: Involvement of Th17 cells in patients of
urothelial carcinoma of bladder. Hum Immunol. 74:1258–1262. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li J, Lau G, Chen L, Yuan YF, Huang J, Luk
JM, Xie D and Guan XY: Interleukin 23 promotes hepatocellular
carcinoma metastasis via NF-kappa B induced matrix
metalloproteinase 9 expression. PLoS One. 7:e462642012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fukuda M, Ehara M, Suzuki S, Ohmori Y and
Sakashita H: IL-23 promotes growth and proliferation in human
squamous cell carcinoma of the oral cavity. Int J Oncol.
36:1355–1365. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu P, Hu HD, Chen M, Peng ML, Tang L, Tang
KF, Matsui M, Belladonna ML, Yoshimoto T, Zhang DZ, et al:
Expression of interleukins-23 and 27 leads to successful gene
therapy of hepatocellular carcinoma. Mol Immunol. 46:1654–1662.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Reay J, Gambotto A and Robbins PD: The
antitumor effects of adenoviral-mediated, intratumoral delivery of
interleukin 23 require endogenous IL-12. Cancer Gene Ther.
19:135–143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jin HT, Youn JI, Choi SY, Seo SH, Park SH,
Song MY, Yang SH and Sung YC: Adenovirus-mediated gene transfer of
interleukin-23 shows prophylactic but not therapeutic antitumor
effects. Cancer Gene Ther. 15:693–702. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
von Scheidt B, Leung PS, Yong MC, Zhang Y,
Towne JE, Smyth MJ and Teng MW: Combined anti-CD40 and anti-IL-23
monoclonal antibody therapy effectively suppresses tumor growth and
metastases. Cancer Res. 74:2412–2421. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li J, Zhang L, Zhang J, Wei Y, Li K, Huang
L, Zhang S, Gao B, Wang X and Lin P: Interleukin 23 regulates
proliferation of lung cancer cells in a concentration-dependent way
in association with the interleukin-23 receptor. Carcinogenesis.
34:658–666. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kortylewski M, Xin H, Kujawski M, Lee H,
Liu Y, Harris T, Drake C, Pardoll D and Yu H: Regulation of the
IL-23 and IL-12 balance by Stat3 signaling in the tumor
microenvironment. Cancer Cell. 15:114–123. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Stewart CA and Trinchieri G: Reinforcing
suppression using regulators: A new link between STAT3, IL-23, and
Tregs in tumor immunosuppression. Cancer Cell. 15:81–83. 2009.
View Article : Google Scholar : PubMed/NCBI
|
